17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-analysis With Bias Assessment

      1 , 1 , 2 , 1
      The American Journal of Sports Medicine
      SAGE Publications

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e126">Background:</h5> <p id="P1">There has been a surge in high level studies investigating platelet rich plasma (PRP) for tendon and ligament injuries. A number of meta-analysis have been published, but few studies have focused exclusively on tendon and ligament pathology. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e131">Purpose:</h5> <p id="P2">To perform a meta-analysis assessing the ability of PRP to reduce pain in patients with tendon and ligament injuries. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e136">Study Design:</h5> <p id="P3">Systematic review and meta-analysis</p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e141">Methods:</h5> <p id="P4">This study followed the PRISMA (Preferred Reporting Items and Systematic Reviews and Meta-Analyses) guidelines. A comprehensive search of the literature was carried out in April 2017 using electronic databases PubMed, MEDLINE, and the Cochrane Library. Only Level I studies were included. Platelet and leukocyte count, injection volume, kit used, participant age/gender, comparator, and activating agent used were recorded. The short-term and long-term efficacy of PRP was assessed using the visual analog scale (VAS), which measures pain intensity. Pathology subgroups (rotator cuff, tendinopathy, ACL, and lateral epicondylitis) were evaluated. Funnel plots and Egger’s test were used to screen for publication bias and sensitivity analysis was performed to evaluate the impact of potential outliers by removing studies one at a time. </p> </div><div class="section"> <a class="named-anchor" id="S5"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e146">Results:</h5> <p id="P5">Thirty-seven articles were included in this review, 21 (1031 participants) of which could be included in the quantitative analysis. The majority of studies published investigated rotator cuff (38.1%) or lateral epicondylitis (38.1%). 17 studies (844 participants) reported short-term VAS data and 14 studies (771 participants) reported long-term VAS data. Overall, long-term follow-up results showed significantly less pain in the PRP group compared to control (WMD: −0.84; 95% CI: −1.23, −0.44; p&lt;0.01). Patients treated for rotator cuff injury (WMD: −0.53; 95% CI: −0.98, −0.09; p=0.02) and lateral epicondylitis (WMD: −1.39; 95% CI: −2.49, −0.29; p=0.01) both reported significantly less pain in the long-term. Substantial heterogeneity was reported at baseline (I <sup>2</sup>: 72.0%, p&lt;0.01), short term follow-up (I <sup>2</sup>: 72.5%, p&lt;0.01), long term follow-up (I <sup>2</sup>: 76.1%, p&lt;0.01), and overall (I <sup>2</sup>: 75.8%, p&lt;0.01). The funnel plot appeared to be asymmetric, with some missingness at the lower right portion of the plot suggesting possible publication bias. </p> </div><div class="section"> <a class="named-anchor" id="S6"> <!-- named anchor --> </a> <h5 class="section-title" id="d9213234e163">Conclusion:</h5> <p id="P6">This review shows that PRP may reduce the pain associated with lateral epicondylitis and rotator cuff pathology. </p> </div>

          Related collections

          Most cited references77

          • Record: found
          • Abstract: found
          • Article: not found

          Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

          The topical use of platelet concentrates is recent and its efficiency remains controversial. Several techniques for platelet concentrates are available; however, their applications have been confusing because each method leads to a different product with different biology and potential uses. Here, we present classification of the different platelet concentrates into four categories, depending on their leucocyte and fibrin content: pure platelet-rich plasma (P-PRP), such as cell separator PRP, Vivostat PRF or Anitua's PRGF; leucocyte- and platelet-rich plasma (L-PRP), such as Curasan, Regen, Plateltex, SmartPReP, PCCS, Magellan or GPS PRP; pure plaletet-rich fibrin (P-PRF), such as Fibrinet; and leucocyte- and platelet-rich fibrin (L-PRF), such as Choukroun's PRF. This classification should help to elucidate successes and failures that have occurred so far, as well as providing an objective approach for the further development of these techniques.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial.

            Tendon disorders comprise 30% to 50% of all activity-related injuries; chronic degenerative tendon disorders (tendinopathy) occur frequently and are difficult to treat. Tendon regeneration might be improved by injecting platelet-rich plasma (PRP), an increasingly used treatment for releasing growth factors into the degenerative tendon. To examine whether a PRP injection would improve outcome in chronic midportion Achilles tendinopathy. A stratified, block-randomized, double-blind, placebo-controlled trial at a single center (The Hague Medical Center, Leidschendam, The Netherlands) of 54 randomized patients aged 18 to 70 years with chronic tendinopathy 2 to 7 cm above the Achilles tendon insertion. The trial was conducted between August 28, 2008, and January 29, 2009, with follow-up until July 16, 2009. Eccentric exercises (usual care) with either a PRP injection (PRP group) or saline injection (placebo group). Randomization was stratified by activity level. The validated Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire, which evaluated pain score and activity level, was completed at baseline and 6, 12, and 24 weeks. The VISA-A score ranged from 0 to 100, with higher scores corresponding with less pain and increased activity. Treatment group effects were evaluated using general linear models on the basis of intention-to-treat. After randomization into the PRP group (n = 27) or placebo group (n = 27), there was complete follow-up of all patients. The mean VISA-A score improved significantly after 24 weeks in the PRP group by 21.7 points (95% confidence interval [CI], 13.0-30.5) and in the placebo group by 20.5 points (95% CI, 11.6-29.4). The increase was not significantly different between both groups (adjusted between-group difference from baseline to 24 weeks, -0.9; 95% CI, -12.4 to 10.6). This CI did not include the predefined relevant difference of 12 points in favor of PRP treatment. Among patients with chronic Achilles tendinopathy who were treated with eccentric exercises, a PRP injection compared with a saline injection did not result in greater improvement in pain and activity. clinicaltrials.gov Identifier: NCT00761423.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration

              Fibroblast growth factors (FGFs) that signal through FGF receptors (FGFRs) regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation. The FGF signal pathways are the RAS/MAP kinase pathway, PI3 kinase/AKT pathway, and PLCγ pathway, among which the RAS/MAP kinase pathway is known to be predominant. Several studies have recently implicated the in vitro biological functions of FGFs for tissue regeneration. However, to obtain optimal outcomes in vivo, it is important to enhance the half-life of FGFs and their biological stability. Future applications of FGFs are expected when the biological functions of FGFs are potentiated through the appropriate use of delivery systems and scaffolds. This review will introduce the biology and cellular functions of FGFs and deal with the biomaterials based delivery systems and their current applications for the regeneration of tissues, including skin, blood vessel, muscle, adipose, tendon/ligament, cartilage, bone, tooth, and nerve tissues.
                Bookmark

                Author and article information

                Journal
                The American Journal of Sports Medicine
                Am J Sports Med
                SAGE Publications
                0363-5465
                1552-3365
                June 28 2018
                July 2018
                December 21 2017
                July 2018
                : 46
                : 8
                : 2020-2032
                Affiliations
                [1 ]Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
                [2 ]Southern California Clinical and Translational Science Institute, Los Angeles, California, USA
                Article
                10.1177/0363546517743746
                6339617
                29268037
                cce35828-cb16-4c1a-818e-f6f52d7801ff
                © 2018

                http://journals.sagepub.com/page/policies/text-and-data-mining-license

                History

                Comments

                Comment on this article